The Institute for Cancer Vaccines and Immunotherapy

4th International Symposium on Immunotherapy
will be held at The Royal Society in London on the 24th – 25th May 2019.

Registration is now open for this event.

The last meeting in 2017 has been summarised in Cancer Immunology and Immunotherapy.

ARTICLE | JOURNAL

Since the ICVI’s last meeting in 2017 the impact of immunotherapy has been dramatic and extensive involving many new tumour types. This meeting will discuss issues including the many specific agents such as IDO inhibitors, Cannabinoid derived drugs, immune immodulators and CAR-T cell immunotherapy.

Experts at our previous meeting agreed that all immunotherapies could benefit from combinations. Five speakers showed enhanced responses to vaccines with the addition of low dose cyclophosphamide even though the doses and regimens were different. We will build on this during the 2019 symposium.

We are pleased to announce that The Royal College of Pathologists have awarded this event 10 CPD points.

Key themes of the 2019 symposium will be:

• Car-T cells immunotherapy, from T cells to ultimate adoptive immunotherapy
• How to enhance check point inhibitor activity
• The role of Cannabinoids such as CBD, CBG etc in the enhancement of anticancer activity
• Vaccines and other Immunotherapies

We are delighted to announce that the following speakers will be talking at our event:

Dr Irving Lerner WeissmanInstitute for Stem Cell Biology and Regenerative Medicine Director, Stanford Ludwig Center for Cancer Stem Cell Research and Medicine Professor of Pathology and Developmental Biology, Stanford UniveristyDr Bernard FoxHarder Family Chair for Cancer Research, Robert W. Franz Cancer Research Center
Natasha Brockwellfinal year PhD student, La Trobe Institute for Molecular SciencesDr Rachael ZemekPostdoctoral Researcher, University of Western Australia
Professor Carl JuneDirector of the Parker Institute for Cancer Immunotherapy, University of PennsylvaniaProfessor Adrian HaydayKings College London
Professor John MaherConsultant in Immunology, King's College LondonProfessor Vincenzo BronteUniversity of Verona
Professor Paul SondelReed and Carolee Walker Professor, Departments of Pediatrics, University of Wisconsin, Madison WI, USAProfessor Samir KhleifDirector of the State of Georgia Cancer Center, Georgia Regents University Cancer Center and the Cancer Service Line
Professor Raj ChopraDirector, Cancer Research UK, Cancer Therapeutics Unit, Head, Division of Cancer Therapeutics, The Institute of Cancer Research
Professor Robert HawkinsDivision of Cancer Sciences, University of Manchester
Professor Marco FalascaCurtin University, PerthDr Michael ShurinProfessor of Pathology, University of Pittsburgh Medical Center
Dr Pan PantziarkaProgram Director, Anticancer FundProfessor Robin WeissEmeritus Professor of Viral Oncology, University College London
Professor Viktor UmanskyGroup leader/Principal investigator, Skin Cancer Unit, German Cancer Research Center (DKFZ)
Professor Simon Wain Hobsoninvectys
Ms Nadine HallSt Georges University of LondonDr Julian KenyonIntegrated Medicine Physician and Medical Director, Dove Clinic for Integrated Medicine
Dr Richard VileMayo Clinic, USADr Sarah HowlettCharing Cross Hospital
Dr Gaia ZuccolottoUniversity of PadovaDr Alexei Kirkin
Professor Lindy DurrantProfessor of Cancer Immunotherapy, The University of Nottingham, Joint CEO and CSO of Scancell Ltd
Ms Sharon ChenUniversity of Southern California
Ms Lucine MarotteINSERM

Further speakers will be announced in the near future.

ICVI Symposium Rates 2019

1 day – early bird 2 days – early bird 1 day – standard rate 2 days – standard rate
Pharma £370 £420 £420 £470
Academics £270 £320 £330 £370
Students £180 £230 £215 £275

Early Bird rates have now ended

Abstract Deadline: passed – if you have any queries please email me at abi@icvi.org.uk

 

Register for your place now.